Top

Published in:

Open Access 13-11-2024 | Glioblastoma | Research

Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro

Authors: Xolisile Mokoena, Peace Mabeta, Werner Cordier, Brian Thabile Flepisi

Published in: Journal of Neuro-Oncology | Issue 2/2025

Abstract

Background

Glioblastoma (GBM) is an aggressive therapy-resistant brain tumour that may impacts the integrity of the blood–brain barrier (BBB). The BBB is a protective barrier of the central nervous system formed mainly by endothelial cells. This study aimed to investigate the in vitro effect of GBM cells on the BBB.

Methods

Brain endothelial (bEnd.3) cells were used as a model of the BBB. Glioblastoma-conditioned media (CM) was extracted at the 48-h (h) time-point from the U87 GBM cells and diluted to 40% with fresh media. The effect of the U87-CM collected at 48 h on bEnd.3 cell growth was evaluated following 48 and 72 h of treatment using the xCELLigence system. Additionally, bEnd.3 cell growth was also investigated in a U87 and bEnd.3 co-culture model continuously for 48 h using the xCELLigence system. The migration of bEnd.3 cells was assessed following 48 and 72 h using the migration scratch assay. The barrier integrity was evaluated continuously for 1 h using the transwell permeability, and the tight junction (TJ) protein expression was evaluated using Western blot assay following 48 and 72 h.

Results

There was a significant decrease in bEnd.3 cell growth following 32 h (p < 0.05), 40 h (p < 0.01), and 48 h (p < 0.001) of treatment with U87-CM, while co-culturing of bEnd.3 and U87 cells increased cell growth following 16 h (p < 0.05), 24 h (p < 0.001), 32 h (p < 0.01), 40 h (p < 0.001), and 48 h (p < 0.001). The migration of bEnd.3 cells significantly increased following both 24 (p < 0.05) and 48 h (p < 0.01) of treatment with U87-CM. The permeability of bEnd.3 cells co-cultured with U87 for 48 h was significantly increased (p < 0.05) at the 15- and 30-min time points. Furthermore, the expression of ZO-1 and occludin was significantly increased (p < 0.05) in both bEnd.3 cells treated with U87-CM as well as bEnd.3 cells co-cultured with U87 cells.

Conclusion

The current findings suggest that U87 cells alter the integrity of bEnd.3 cells possibly through the secretomes in the CM and through cell–cell interactions in co-culture models. This may assist in the understanding of the mechanisms by which GBM affects the BBB, which may aid in the management thereof.

Available only for authorised users

Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13–25. https://doi.org/10.1016/j.nbd.2009.07.030CrossRefPubMed

Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19(12):1584–1596. https://doi.org/10.1038/nm.3407CrossRefPubMedPubMedCentral

Profaci CP, Munji RN, Pulido RS, Daneman R (2020) The blood-brain barrier in health and disease: important unanswered questions. J Exp Med 217(4):e20190062. https://doi.org/10.1084/jem.20190062CrossRefPubMedPubMedCentral

Chen Z, Li G (2021) Immune response and blood-brain barrier dysfunction during viral neuroinvasion. Innate Immun 27(2):109–117. https://doi.org/10.1177/1753425920954281CrossRefPubMed

Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21–78. https://doi.org/10.1152/physrev.00050.2017CrossRefPubMed

Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412. https://doi.org/10.1101/cshperspect.a020412CrossRefPubMedPubMedCentral

Wilhelm I, Nyúl-Tóth Á, Suciu M, Hermenean A, Krizbai IA (2016) Heterogeneity of the blood-brain barrier. Tissue Barriers 4(1):e1143544. https://doi.org/10.1080/21688370.2016.1143544CrossRefPubMedPubMedCentral

Turowski P, Kenny BA (2015) The blood-brain barrier and methamphetamine: open sesame? Front Neurosci 9:156. https://doi.org/10.3389/fnins.2015.00156CrossRefPubMedPubMedCentral

Spindler KR, Hsu TH (2012) Viral disruption of the blood-brain barrier. Trends Microbiol 20(6):282–290. https://doi.org/10.1016/j.tim.2012.03.009CrossRefPubMedPubMedCentral

10.

Lee SW, Kim WJ, Park JA, Choi YK, Kwon YW, Kim KW (2006) Blood-brain barrier interfaces and brain tumors. Arch Pharm Res 29(4):265–275. https://doi.org/10.1007/BF02968569CrossRefPubMed

11.

Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20(1):26–41. https://doi.org/10.1038/s41568-019-0205-xCrossRefPubMed

12.

Banerjee S, Bhat MA (2007) Neuron-glial interactions in blood-brain barrier formation. Annu Rev Neurosci 30:235–258. https://doi.org/10.1146/annurev.neuro.30.051606.094345CrossRefPubMedPubMedCentral

13.

Wong ET, Brem S (2008) Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. J Natl Compr Canc Netw 6(5):515–522. https://doi.org/10.6004/jnccn.2008.0039CrossRefPubMed

14.

Chowdhary S, Chamberlain MC (2018) CSF Dissemination of Primary Brain Tumors [Internet]. 2nd ed. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc. 191–209: https://doi.org/10.1016/B978-0-12-812100-9.00014-0

15.

Wang C, Li J, Sinha S, Peterson A, Grant GA, Yang F (2019) Mimicking brain tumor-vasculature microanatomical architecture via co-culture of brain tumor and endothelial cells in 3D hydrogels. Biomaterials 202:35–44. https://doi.org/10.1016/j.biomaterials.2019.02.024CrossRefPubMedPubMedCentral

16.

Mabeta P, Pepper MS (2015) Altered expression of platelet factor 4 and basic fibroblast growth factor correlates with the inhibition of tumor growth in mice. Biomed Pharmacother 69:186–190. https://doi.org/10.1016/j.biopha.2014.11.018CrossRefPubMed

17.

Mabeta P, Pepper MS (2009) A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Angiogenesis 12(1):81–90. https://doi.org/10.1007/s10456-009-9134-8CrossRefPubMed

18.

Czupalla CJ, Liebner S, Devraj K (2014) In vitro models of the blood-brain barrier. Methods Mol Biol 1135:415–437. https://doi.org/10.1007/978-1-4939-0320-7_34CrossRefPubMed

19.

Watanabe T, Dohgu S, Takata F, Nishioku T, Nakashima A, Futagami K, Yamauchi A, Kataoka Y (2013) Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bEND.3, bEND.5 and mouse brain endothelial cell 4. Biol Pharm Bull 36(3):492–495. https://doi.org/10.1248/bpb.b12-00915CrossRefPubMed

20.

Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76–85. https://doi.org/10.1016/0003-2697(85)90442-7CrossRefPubMed

21.

Quick S, Moss J, Rajani RM, Williams A (2021) A vessel for change: endothelial dysfunction in cerebral small vessel disease. Trends Neurosci 44(4):289–305. https://doi.org/10.1016/j.tins.2020.11.003CrossRefPubMed

22.

Charalambous C, Hofman FM, Chen TC (2005) Functional and phenotypic differences between glioblastoma multiforme—derived and normal human brain endothelial cells. J Neurosurg 102(4):699–705. https://doi.org/10.3171/jns.2005.102.4.0699CrossRefPubMed

23.

Kenig S, Alonso MBD, Mueller MM, Lah TT (2010) Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett 289(1):53–61. https://doi.org/10.1016/j.canlet.2009.07.014CrossRefPubMed

24.

Ezhilarasan R, Mohanam I, Govindarajan K, Mohanam S (2007) Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process. Int J Oncol 30(3):701–707PubMed

25.

Okawa S, Gagrica S, Blin C, Ender C, Pollard SM, Krijgsveld J (2017) Proteome and secretome characterization of glioblastoma-derived neural stem cells. Stem Cells 35(4):967–980. https://doi.org/10.1002/stem.2542CrossRefPubMed

26.

Schiera G, Di Liegro CM, Di Liegro I (2017) Molecular determinants of malignant brain cancers: from intracellular alterations to invasion mediated by extracellular vesicles. Int J Mol Sci 18(12):2774. https://doi.org/10.3390/ijms18122774CrossRefPubMedPubMedCentral

27.

Dwyer J, Hebda JK, Le Guelte A, Galan-Moya EM, Smith SS, Azzi S, Bidere N, Gavard J (2012) Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS ONE 7(9):e45562. https://doi.org/10.1371/journal.pone.0045562CrossRefPubMedPubMedCentral

28.

Oliveira Rosario DE, LV, DA Rosa BG, Goncalves TL, Matias DIL, Freitas C, Ferrer VP, (2020) Glioblastoma factors increase the migration of human brain endothelial cells in vitro by increasing MMP-9/CXCR4 Levels. Anticancer Res 40(5):2725–2737. https://doi.org/10.21873/anticanres.14244CrossRefPubMed

29.

Norton KA, Popel AS (2016) Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep 6:36992. https://doi.org/10.1038/srep36992CrossRefPubMedPubMedCentral

30.

Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67(2):275–282. https://doi.org/10.1002/(SICI)1097-0215(19960717)67:2%3c275::AID-IJC20%3e3.0.CO;2-9CrossRefPubMed

31.

Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV (2007) Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 101(6):570–580. https://doi.org/10.1161/CIRCRESAHA.107.155655CrossRefPubMedPubMedCentral

32.

da Cunha BR, Domingos C, Stefanini ACB, Henrique T, Polachini GM, Castelo-Branco P, Tajara EH (2019) Cellular interactions in the tumor microenvironment: the role of secretome. J Cancer 10(19):4574–4587. https://doi.org/10.7150/jca.21780CrossRefPubMedPubMedCentral

33.

Yang S, Mei S, Jin H, Zhu B, Tian Y, Huo J, Cui X, Guo A, Zhao Z (2017) Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier. PLoS ONE 12(10):e0187017. https://doi.org/10.1371/journal.pone.0187017CrossRefPubMedPubMedCentral

34.

Rado M, Flepisi B, Fisher D (2022) The effect of normoxic and hypoxic U-87 glioblastoma paracrine secretion on the modulation of brain endothelial cells. Cells 11(2):276. https://doi.org/10.3390/cells11020276CrossRefPubMedPubMedCentral

35.

Mendes B, Marques C, Carvalho I, Costa P, Martins S, Ferreira D, Sarmento B (2015) Influence of glioma cells on a new co-culture in vitro blood-brain barrier model for characterization and validation of permeability. Int J Pharm 490(1–2):94–101. https://doi.org/10.1016/j.ijpharm.2015.05.027CrossRefPubMed

36.

Erickson MA, Wilson ML, Banks WA (2020) In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS 17(1):26. https://doi.org/10.1186/s12987-020-00187-3CrossRefPubMedPubMedCentral

37.

Deli MA, Abrahám CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25(1):59–127. https://doi.org/10.1007/s10571-004-1377-8CrossRefPubMed

38.

Huang X, Hussain B, Chang J (2021) Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27(1):36–47. https://doi.org/10.1111/cns.13569CrossRefPubMed

39.

Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, Schwartz MA, Matter K, Balda MS (2015) ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208(6):821–838. https://doi.org/10.1083/jcb.201404140CrossRefPubMedPubMedCentral

40.

Maiuolo J, Gliozzi M, Musolino V, Scicchitano M, Carresi C, Scarano F et al (2018) The “frail” brain blood barrier in neurodegenerative diseases: role of early disruption of endothelial cell-to-cell connections. Int J Mol Sci 19(9):2693–2709. https://doi.org/10.3390/ijms19092693CrossRefPubMedPubMedCentral

41.

Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T, Shen Y, Liu X (2013) Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci 9(9):966–979. https://doi.org/10.7150/ijbs.6996CrossRefPubMedPubMedCentral

42.

Osada T, Gu YH, Kanazawa M, Tsubota Y, Hawkins BT, Spatz M, Milner R, del Zoppo GJ (2011) Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by β(1)-integrins. J Cereb Blood Flow Metab 31(10):1972–1985. https://doi.org/10.1038/jcbfm.2011.99CrossRefPubMedPubMedCentral

Title: Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro
Authors: Xolisile Mokoena
Peace Mabeta
Werner Cordier
Brian Thabile Flepisi
Publication date: 13-11-2024
Publisher: Springer US
Keywords: Glioblastoma
Glioblastoma
Glioblastoma
Published in: Journal of Neuro-Oncology / Issue 2/2025
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-024-04870-5

Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases

Metastasis
Case Study

Early experience with an artificial intelligence-based module for brain metastasis detection and segmentation

Artificial Intelligence
Research

Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol

Glioblastoma
Research

Targeting the RAS/MAPK pathway in children with glioma

Glioma
Review

Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database

Glioblastoma
Case Study

Correction to: A case series and review of stereotactic body radiation therapy for contiguous multilevel spine metastases

Metastasis
Correction

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Advances in Alzheimer's

Alzheimer Disease
Independent Medical Education

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:

Lilly

Developed by: Springer Healthcare IME

Learn more

Podcast | Sexual health in older age

Springer Medicine

Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro

Abstract

Background

Methods

Results

Conclusion

Other articles of this Issue 2/2025

Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases

Early experience with an artificial intelligence-based module for brain metastasis detection and segmentation

Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol

Targeting the RAS/MAPK pathway in children with glioma

Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database

Correction to: A case series and review of stereotactic body radiation therapy for contiguous multilevel spine metastases

Keynote series | Spotlight on menopause

Advances in Alzheimer's

Podcast | Sexual health in older age

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content